Nodality, Inc., a biotechnology company, discovers and develops personal diagnostics characterizing cell signaling pathways in defined cellular sub-populations of malignant and normal cells from individual patients. The company focuses on hematological malignancies and autoimmune disorders. Nodality, Inc. was incorporated in 2003 and is based in San Francisco, California with an additional office in Franklin, Tennessee.
Funding Rounds (5) - $27.04MUpdate
Current Team (9)Update
201 Gateway Boulevard
South San Francisco, CA 94080